Appeals Court Greenlights Sales Of Zarxio, The First FDA-Approved Biosimilar Drug
Thursday, July 23, 2015 - 12:30
in Mathematics & Economics
Biologics: But the clock has not run out on possible patent infringement suits by Amgen, developer of the originator drug, Neupogen